Study of RP-3500, Camonsertib, in Advanced Solid Tumors

#1004, Memorial Sloan Kettering Cancer Institute, New York

#1005, Duke Cancer Institute, Durham

#1003, Sarah Cannon Research Institute, Nashville

#1014, Northwestern University, Chicago

#1001, The University of Texas M.D. Anderson Cancer Center, Houston

#1006, Massachusetts General Hospital, Boston

#1002, Dana Farber Cancer Institute, Boston

#1007, Rhode Island Hospital, Providence

#2001, Princess Margaret Cancer Centre, Toronto

#4001, Copenhagen University Hospital Rigshospitalet - Blegdamsvej, Copenhagen

#3003, Sarah Cannon Research Institute, London

#3001, The Christie NHS Foundation Trust, Manchester

#3002, Freeman Hospital Newcastle, Newcastle upon Tyne